Resverlogix

Provider of small molecule BET-inhibitors for CV disease for treating diabetes

placeCalgary, Alberta, Canada calendar_todayFounded 2001 groups19 employees language resverlogix.com

Innovation

28 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing.

Social engagement

Social engagement: 1.9K social following, 1 post in the last 12 months — below the industry typical range.

Recent activity

18 Nov 2025
Leadership hire
Board of Directors
Coming soon